Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ.
about
PGC-1α, mitochondrial dysfunction, and Huntington's diseaseImpaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtinPPARγ as a therapeutic target to rescue mitochondrial function in neurological diseaseHdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid AccumulationEarly deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease.Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese statusPPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically.Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease.Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease.Rosiglitazone regulates anti-inflammation and growth inhibition via PTEN.Prospects for neuroprotective therapies in prodromal Huntington's disease.Sulforaphane induces autophagy through ERK activation in neuronal cells.Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3) has a key role in the mitochondrial dysfunction induced by mutant huntingtin.
P2860
Q27001671-B5CD8675-61BA-4C9B-8028-3A5578195C9AQ27312215-463B89EE-A80A-4285-9471-276BDA0DD95DQ28069549-742165DD-FD7D-41CB-85B4-1397C71AACDCQ28386493-0755B34E-880D-4734-9C18-D4269967A928Q35058593-4F97F848-4CEE-4DC3-A4DC-E3D68413EE12Q35079642-3A614589-6E35-409A-A9CD-B634B5A3F7D1Q36575566-BA50D8E9-E203-451F-9BA0-2EC6EAF707D0Q36813115-4300BE2C-5D81-440C-B50E-76A8D9BB2AF3Q37427280-7CEBFF09-1BFD-4E87-A0EA-748632D703F3Q37677252-FF93587E-83AC-4724-9452-98637801EA6BQ38191477-2497FA68-ADF3-4912-B1E2-947B5445C542Q38982423-85FFC6B9-7018-48CA-A1EC-F2C315A42E65Q45289973-04555829-7051-4D0A-BA40-C37C0396FFCC
P2860
Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Metabolic state determines sen ...... zation by activation of PPARγ.
@ast
Metabolic state determines sen ...... zation by activation of PPARγ.
@en
Metabolic state determines sen ...... zation by activation of PPARγ.
@nl
type
label
Metabolic state determines sen ...... zation by activation of PPARγ.
@ast
Metabolic state determines sen ...... zation by activation of PPARγ.
@en
Metabolic state determines sen ...... zation by activation of PPARγ.
@nl
prefLabel
Metabolic state determines sen ...... zation by activation of PPARγ.
@ast
Metabolic state determines sen ...... zation by activation of PPARγ.
@en
Metabolic state determines sen ...... zation by activation of PPARγ.
@nl
P2093
P2860
P1433
P1476
Metabolic state determines sen ...... zation by activation of PPARγ.
@en
P2093
Chulman Jo
Gail V W Johnson
Woong Y Hwang
Youngnam N Jin
P2860
P304
P356
10.1371/JOURNAL.PONE.0030406
P407
P577
2012-01-20T00:00:00Z